Connexion
S'inscrire
Réinitialiser le mot de passe
Publier & Distribuer
Solutions d'édition
Solutions de distribution
Thèmes
Architecture et design
Arts
Business et économie
Chimie
Chimie industrielle
Droit
Géosciences
Histoire
Informatique
Ingénierie
Intérêt général
Linguistique et sémiotique
Littérature
Mathématiques
Musique
Médecine
Pharmacie
Philosophie
Physique
Sciences bibliothécaires et de l'information, études du livre
Sciences des matériaux
Sciences du vivant
Sciences sociales
Sport et loisirs
Théologie et religion
Études classiques et du Proche-Orient ancient
Études culturelles
Études juives
Publications
Journaux
Livres
Comptes-rendus
Éditeurs
Blog
Contact
Chercher
EUR
USD
GBP
Français
English
Deutsch
Polski
Español
Français
Italiano
Panier
Home
Journaux
Revista Romana de Medicina de Laborator
Édition 21 (2013): Edition 3 (September 2013)
Accès libre
The importance of the new prognostic scoring system for evaluating patients with lower-risk myelodysplastic syndrome at diagnosis
Aurelia Tatic
Aurelia Tatic
,
Cerasela Jardan
Cerasela Jardan
,
Otilia Georgescu
Otilia Georgescu
,
Oana Stanca
Oana Stanca
,
Madalina Vasilica
Madalina Vasilica
,
Sorina Badelita
Sorina Badelita
,
Ana Manuela Crisan
Ana Manuela Crisan
,
Adriana Colita
Adriana Colita
,
Dan Colita
Dan Colita
,
Genica Vulcan
Genica Vulcan
,
Anca Roxana Lupu
Anca Roxana Lupu
,
Ionel Iosif
Ionel Iosif
et
Daniel Coriu
Daniel Coriu
| 19 sept. 2013
Revista Romana de Medicina de Laborator
Édition 21 (2013): Edition 3 (September 2013)
À propos de cet article
Article précédent
Article suivant
Résumé
Références
Auteurs
Articles dans cette édition
Aperçu
PDF
Citez
Partagez
Publié en ligne:
19 sept. 2013
Pages:
343 - 351
DOI:
https://doi.org/10.2478/rrlm-2013-0033
This content is open access.
Aurelia Tatic
Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania
University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania
Cerasela Jardan
Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania
University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania
Otilia Georgescu
Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania
Oana Stanca
Hematology Department, Coltea Hospital, Bucharest, Romania
University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania
Madalina Vasilica
Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania
Sorina Badelita
Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania
Ana Manuela Crisan
Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania
University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania
Adriana Colita
Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania
Dan Colita
Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania
Genica Vulcan
Hiperdia, Brasov, Romania
Anca Roxana Lupu
Hematology Department, Coltea Hospital, Bucharest, Romania
University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania
Ionel Iosif
National Centre for Prevention and Diseases Control, Bucharest, Romania
Daniel Coriu
Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania
University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania